Humacyte
Latest round
- Series C
Last raised
- Feb 2018
Total raised
- $225M
Investors
- 5
About Humacyte
Based in North Carolina, and founded in 2004 US, Humacyte, Inc. is a biotechnology company that develops human tissue-based products for vascular diseases and replacement of anatomical conduits. The company was co-founded by Dr. Laura Niklason, Dr. Niklason, Dr. Shannon Dahl, and Dr. Juliana Blum and has approximately 122 employees. The company's platform utilizes technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues that enable patients to significantly improve treatment outcomes, including those with vascular disease and those requiring hemodialysis. The company generates revenue through developing pharmaceutical therapies. The company plans to expand its market and has 2 Phase 3 ongoing trials that are expected to have results by 2023.
Who invested in Humacyte
5 investors across 2 rounds
See all investors in Humacyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Humacyte
Who invested in Humacyte?
Humacyte has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Humacyte raised?
Humacyte has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Humacyte last raise money?
Humacyte's most recent round on record is a Series C, in Feb 2018.
What does Humacyte do?
Based in North Carolina, and founded in 2004 US, Humacyte, Inc.
Where is Humacyte headquartered?
Humacyte is headquartered in Durham, US.
Which VCs invest in companies like Humacyte?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Humacyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Humacyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.